{"product_id":"scripps-38th-annual-new-treatments-in-chronic-liver-disease-2024","title":"Scripps 38th Annual New Treatments in Chronic Liver Disease 2024","description":"\u003cheader class=\"section__headings section__headings___edc6e\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cdiv class=\"card-header bg-transparent py-4 px-3\"\u003e\n\u003ch4 class=\"product_title entry-title\"\u003eScripps 38th Annual New Treatments in Chronic Liver Disease 2024\u003c\/h4\u003e\n\u003cp\u003eScripps 38th Annual New Treatments in Chronic Liver Disease 2024\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e Include: 16 videos + 1 pdf, size: 2.23 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Target Audience: hepatologists, gastroenterologists, infectious disease physician\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Sample video: \u003ca href=\"https:\/\/medustudent.com\/contact_us\/\"\u003econtact me\u003c\/a\u003e for sample video\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cp\u003e\u003cstrong\u003eCourse Overview\u003c\/strong\u003e\u003cbr\u003e\nThis conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\u003cbr\u003e\nAfter attending this live activity, participants should be able to:\u003cbr\u003e\n• Assess new therapies for curing Delta Hepatitis and Hepatitis B.\u003cbr\u003e\n• Review guidelines for the management of cholestatic liver diseases.\u003cbr\u003e\n• Outline recent advances in the understanding and management of ascites and hepatorenal syndrome.\u003cbr\u003e\n• Evaluate drugs in development for metabolic liver disease.\u003cbr\u003e\n• Address causes and trends of liver disease and liver transplantation in women.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003e\n• Hepatologists\u003cbr\u003e\n• Gastroenterologists\u003cbr\u003e\n• Infectious Disease Specialists\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ebrochure_for_web_liver24.pdf\u003c\/li\u003e\n\u003cli\u003eESLD, HCC AND TRANSPLANTATION Advances in the Treatment of HCC.mp4\u003c\/li\u003e\n\u003cli\u003eESLD, HCC AND TRANSPLANTATION Chronic Liver Disease and Liver Transplantation in Women.mp4\u003c\/li\u003e\n\u003cli\u003eESLD, HCC AND TRANSPLANTATION Panel Discussion Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eESLD, HCC AND TRANSPLANTATION Update of AASLD Guidelines on Portal Hypertension.mp4\u003c\/li\u003e\n\u003cli\u003eESLD, HCC AND TRANSPLANTATION WILLIAM S. HAUBRICH LECTURE- Renal Dysfunction in the Cirrhotic Patient.mp4\u003c\/li\u003e\n\u003cli\u003eEVOLVING THERAPIES FOR ADVANCED LIVER CARE Alcohol Liver Disease.mp4\u003c\/li\u003e\n\u003cli\u003eEVOLVING THERAPIES FOR ADVANCED LIVER CARE Cholestatic Liver Diseases.mp4\u003c\/li\u003e\n\u003cli\u003eEVOLVING THERAPIES FOR ADVANCED LIVER CARE Colocalization of Addiction Medicine.mp4\u003c\/li\u003e\n\u003cli\u003eEVOLVING THERAPIES FOR ADVANCED LIVER CARE Emerging Therapies for Delta Hepatitis and Hepatitis B.mp4\u003c\/li\u003e\n\u003cli\u003eEVOLVING THERAPIES FOR ADVANCED LIVER CARE Management of Liver Masses.mp4\u003c\/li\u003e\n\u003cli\u003eEVOLVING THERAPIES FOR ADVANCED LIVER CARE Panel Discussion Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eIDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Diversity in MASH.mp4\u003c\/li\u003e\n\u003cli\u003eIDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Incretins for Metabolic Liver Disease.mp4\u003c\/li\u003e\n\u003cli\u003eIDENTIFYING AND MANAGING METABOLIC LIVER DISEASE New Nomenclature for Steatotic Liver Disease .mp4\u003c\/li\u003e\n\u003cli\u003eIDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Panel Discussion Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eIDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Selective Thyroid Hormone Receptor- Beta (TRá) Agonists for MASH.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954605690978,"sku":"MED-AMB06917","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-38th-Annual-New-Treatments-in-Chronic-Liver-Disease-2024.jpg?v=1779380522","url":"https:\/\/meducourse.com\/products\/scripps-38th-annual-new-treatments-in-chronic-liver-disease-2024","provider":"Meducourse","version":"1.0","type":"link"}